Price T Rowe Associates Inc Enochian Biosciences Inc Transaction History
Price T Rowe Associates Inc
- $812 Billion
- Q1 2025
A detailed history of Price T Rowe Associates Inc transactions in Enochian Biosciences Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 45,198 shares of ENOB stock, worth $207,910. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45,198
Previous 45,198
-0.0%
Holding current value
$207,910
Previous $38,000
34.21%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ENOB
# of Institutions
58Shares Held
15.8MCall Options Held
101KPut Options Held
23.3K-
Vanguard Group Inc Valley Forge, PA4.92MShares$22.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.66MShares$16.8 Million0.0% of portfolio
-
State Street Corp Boston, MA2MShares$9.21 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.02MShares$4.67 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL832KShares$3.83 Million0.0% of portfolio
About Enochian Biosciences Inc
- Ticker ENOB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,950,000
- Market Cap $244M
- Description
- Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...